|
|
Volumn 20, Issue 2, 2014, Pages
|
|
Special considerations for prophylaxis for and treatment of anthrax in pregnant and postpartum women.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTHRAX VACCINE;
ANTIBIOTIC AGENT;
ANTIINFECTIVE AGENT;
ANTITOXIN;
MONOCLONAL ANTIBODY;
RAXIBACUMAB;
VACCINE;
ADULT;
ANTHRAX;
ANTIBACTERIAL AGENTS;
ANTIMICROBIAL DRUGS;
BACILLUS ANTHRACIS;
BACTERIUM;
BIOLOGICAL WARFARE;
BREAST-FEEDING;
CONFERENCE PAPER;
DRUG EFFECT;
FEMALE;
FETUS;
HUMAN;
IMMUNOLOGY;
INFANT;
LACTATION;
MICROBIOLOGY;
PATHOGENICITY;
PEP;
POST EXPOSURE PROPHYLAXIS;
PRACTICE GUIDELINE;
PREGNANCY;
PREGNANCY COMPLICATION;
PUBLIC HEALTH SERVICE;
PUERPERIUM;
TREATMENT;
UNITED STATES;
VACCINATION;
ANTHRAX;
ANTIBACTERIAL AGENTS;
ANTIBIOTICS;
ANTIMICROBIAL DRUGS;
ANTITOXINS;
BACILLUS ANTHRACIS;
BACTERIA;
BREAST-FEEDING;
LACTATION;
PEP;
POSTEXPOSURE PROPHYLAXIS;
POSTPARTUM PERIOD;
PREGNANCY;
TREATMENT;
VACCINATION;
VACCINE;
WOMEN;
ADULT;
ANTHRAX;
ANTHRAX VACCINES;
ANTI-BACTERIAL AGENTS;
ANTIBODIES, MONOCLONAL;
ANTITOXINS;
BACILLUS ANTHRACIS;
BIOTERRORISM;
CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.);
FEMALE;
FETUS;
HUMANS;
INFANT;
LACTATION;
POSTPARTUM PERIOD;
PRACTICE GUIDELINES AS TOPIC;
PREGNANCY;
PREGNANCY COMPLICATIONS, INFECTIOUS;
UNITED STATES;
|
|
EID: 84899875704
PISSN: None
EISSN: 10806059
Source Type: Journal
DOI: 10.3201/eid2002.130611 Document Type: Conference Paper |
|
Times cited : (35)
|
|
References (0)
|
